Literature DB >> 11325211

Acute myocardial infarction after transurethral resection of the prostate.

R G Hahn1.   

Abstract

Several factors inherent in the transurethal resection of the prostate (TURP) procedure may impose stress on the cardiovascular system. The risk of acute myocardial infarction (AMI) is usually considered to be low but has still been an issue during the last 10 years. Interestingly, the concerns are focused on a possible adverse effect of TURP on the long-term risk of AMI and on survival. Selection bias has been a problem in many of the published studies, however. Co-morbidity is also difficult to handle when the follow-up lasts for several years, in particular since benign prostatic enlargement alone seems to be associated with an increased risk of cardiovascular disease.

Entities:  

Mesh:

Year:  2001        PMID: 11325211     DOI: 10.1016/s0753-3322(01)00039-7

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

1.  The difference in oxidative stress of the blood between using 5% glucose water and distilled water as the irrigant for BPH patients undergoing transurethral resection of the prostate.

Authors:  Shiou-Sheng Chen; Shi-Bei Wu; Yau-Huei Wei
Journal:  World J Urol       Date:  2009-06-27       Impact factor: 4.226

2.  Evaluation of efficacy and safety of improved transurethral plasma kinetic enucleation of the prostate in high-risk patients with benign prostatic hyperplasia and coronary artery disease.

Authors:  Qingchao Meng; Jingmei Li; Mingfeng Li; Rangxue Qiu
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

Review 3.  Risk of acute myocardial infarction after transurethral resection of prostate in elderly.

Authors:  Claudio de Lucia; Grazia Daniela Femminella; Giuseppe Rengo; Antonio Ruffo; Valentina Parisi; Gennaro Pagano; Daniela Liccardo; Alessandro Cannavo; Paola Iacotucci; Klara Komici; Carmela Zincarelli; Carlo Rengo; Pasquale Perrone-Filardi; Dario Leosco; Fabrizio Iacono; Giuseppe Romeo; Bruno Amato; Nicola Ferrara
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.